Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine supraclavicular block with dexmedetomidine, dexamethasone, or sodium bicarbonate adjuncts
IRCT20140129016415N9Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine, dexmedetomidine, dexamethasone and sodium bicarbonate in None (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Time from injection to onset of sensory block, Time from injection to onset of motor block and 2 more. Started Jun 2022; status: completed.
02
Drugs
ropivacainedexmedetomidinedexamethasonesodium bicarbonate
Beyond the preview
Go deeper on IRCT20140129016415N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140129016415N9.